Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

T-Glimet-P2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Torance Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview T-Glimet-P2 Tablet ER

Glimet-P2 ER tablets combine medications to manage blood glucose. Used alongside diet and exercise, this treatment improves blood sugar control in adults with type 2 diabetes by enhancing insulin effectiveness, thus reducing blood sugar. Follow your doctor's prescribed dosage and duration, taking the medication with food to prevent stomach discomfort. If a dose is missed, take it immediately unless the next dose is imminent; in that case, skip the missed dose and resume your regular schedule. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before starting treatment, inform your physician of any kidney, liver, or heart conditions; pregnant or nursing individuals should also seek medical advice. Kidney function tests will be assessed prior to treatment commencement. Limit alcohol consumption as it may exacerbate side effects.

Uses of T-Glimet-P2 Tablet ER

Managing type 2 diabetes

Major Benefits of T-Glimet-P2 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. T-Glimet-P2 Extended-Release tablets should be administered with a meal.

Common Side effects of T-Glimet-P2 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use T-Glimet-P2 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer T-Glimet-P2 Extended-Release Tablets with food.

How T-Glimet-P2 Tablet ER works:

T-Glimet-P2 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining T-Glimet-P2 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of T-Glimet-P2 Tablet ER during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. Your physician will assess the potential benefits against these risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release T-Glimet-P2 tablets pose a likely risk during lactation. Available human evidence indicates potential transfer to breast milk, possibly harming the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms appear.

KidneyKidneyCAUTION

Extended-release T-Glimet-P2 tablets require careful administration for individuals with impaired kidney function. Dosage modification may be necessary; physician consultation is recommended. The use of extended-release T-Glimet-P2 tablets is contraindicated in patients exhibiting severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when taking T-Glimet-P2 Tablet ER; dosage modification may be necessary. A physician's consultation is advised. T-Glimet-P2 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take T-Glimet-P2 Tablet ER :

Should you forget a dose of T-Glimet-P2 Extended Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About T-Glimet-P2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on T-Glimet-P2 Tablet ER

Drinking alcohol while taking T-Glimet-P2 Tablet ER is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Consult your doctor before using T-Glimet-P2 Tablet ER if you have congestive heart failure, kidney or liver disease, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications (prescription and non-prescription), vitamins, and herbal supplements you are taking.
Metformin, a component of T-Glimet-P2 Tablet ER, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
T-Glimet-P2 ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
T-Glimet-P2 Tablet ER
58
MRP 68
14% off